CD4+ memory stem cells (T SCM ) in pathogenic and non- pathogenic SIV infections Guido Silvestri, MD Yerkes National Primate Research Center Emory University.

Slides:



Advertisements
Similar presentations
Dale and Betty Bumpers Vaccine Research Center National Institute of Allergy and Infectious Diseases National Institutes of Health Richard A. Koup Vaccine.
Advertisements

Evaluation of Human Thymic Function during Health and HIV-1 Infection
Purging the HIV-1 Reservoir Through the Disruption of the PD-1 Pathway
Modified IFN-  subtypes production and chemokine networks in the thymus during acute SIV infection, impact on thymopoiesis Jacques DUTRIEUX.
CAROL VINTON LABORATORY OF DR. JASON BRENCHLEY LABORATORY OF MOLECULAR MICROBIOLOGY NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES NATIONAL INSTITUTES.
Unique integration patterns in an in vitro model of HIV-1 latency. Suha M. Saleh, Dimitrios Vatakis, Andrew Harman, Anthony Cunningham, Paul U. Cameron,
Comparison between Pathogenic and Nonpathogenic SIV Infections and Focus on Mucosal Tissue Compartment Reveal a Critical Role for the.
Should we treat HIV Controllers ? IAS 2013 Pr Olivier Lambotte Department of internal medicine and clinical immunology Bicêtre Hospital, University Paris.
Lack of Innate control of HIV
Potential Role of Viral Properties in the Pathogenesis of AIDS Frank Kirchhoff Institute of Molecular Virology Ulm Medical Center, Germany 6/11.
IL-2 as the adjuvant in FMD vaccine Chunxia su , ph.D. Ningxia Medical University Yinchuan , China.
ANIMAL MODELS HIV Cure Research Training Curriculum The HIV CURE training curriculum is a collaborative project aimed at making HIV cure research science.
Models Systems to Study HIV Emily L. Lowe, Ph.D. Microbiology, Immunology and Molecular Genetics UCLA.
Myeloid dendritic cells and HIV latency in resting T-cells Nitasha A Kumar, Vanessa A Evans, Suha Saleh, Candida de Fonseca Pereira, Paula Ellenberg, Paul.
Probiotic and IL-21 Treatment Promotes Th17 Cell Recovery in ARV-Treatment of Pigtail Macaques Alexandra M. Ortiz Laboratory of Jason Brenchley July 23,
2014 “Towards an HIV Cure” symposium Melbourne The Immune Checkpoints PD-1, LAG-3 and TIGIT are Biomarkers of HIV Infected Cells During ART and Identify.
Dynamic Programming of CD8 + T Cell Effector and Memory Development by Innate Cytokines David Farrar Department of Immunology UT Southwestern Medical Center.
Treg exert differential effects on the proliferation and differentiation of CD8 T cell subsets in chronic HIV-1 infection M. Nikolova 1, M. Muhtarova 1,
Cell- and Tissue-based Measures of Viral Persistence Are Associated with Immune Activation and PD-1-Expressing CD4+ T cells H Hatano 1, V Jain 1, PW Hunt.
The role of PI3K signaling pathways in HIV-1 infection of resting CD4+T-cells Suha Saleh, Paul Cameron, Georgina Sallmann, Anthony Jaworowski, and Sharon.
Future directions in HIV basic science research The hunt for a cure.
Slide 1 of 10 From DC Douek, MD, at Atlanta, GA: April 10, 2013, IAS-USA. IAS–USA Daniel C. Douek, MD, PhD Bethesda, Maryland Immune Activation, HIV Persistence,
Latent infection and cellular reservoirs
Eric S. Rosenberg, M.D. Associate Professor of Medicine Massachusetts General Hospital Harvard Medical School
Rémi Cheynier Victor Appay Anne Hosmalin Gianfranco Pancino Vincent Vieillard Brigitte Autran Françoise Brun-Vezinet Charlotte Charpentier Diane Descamps.
Characteristics of transmitted viruses in acute and early HIV infection Eric Hunter IAC 2010.
2014 “Towards an HIV Cure” Symposium Melbourne IL-21 reduces residual inflammation and virus persistence in ART-treated SIV- infected rhesus macaques Mirko.
Target cell availability dictates mother-to-infant transmission of SIV
Pavel Bostik FMHS Charles University Medical School University Hospital Hradec Kralove Czech Republic DIFFERENTIAL EFFECTS OF (LENTI)VIRUS INFECTION ON.
Novel Approaches: Treatment and HIV Pathogenesis L. Trautmann, Ph.D. VGTI Florida.
Studies of HIV Eradication: a Case for Using NHP Models Guido Silvestri, MD Yerkes National Primate Research Center Emory University School of Medicine.
Future directions in HIV basic science research The hunt for a cure.
KEY CONCEPT Some viral diseases can be prevented with vaccines.
Viral Tissue Reservoirs Are Determined Early and Little Viral RNA Is Detected during Suppression in the Macaque Model Zandrea Ambrose, Ph.D. Division of.
Mirko Paiardini, PhD Emory University, YNPRC
Yerkes National Primate Research Center
Primary HIV-1 Infection Pathogenesis, Diagnosis, and Treatment Summary of Evidence Martin Markowitz M.D. Clinical Director and Staff Investigator Aaron.
SIVagm infection of rhesus macaques: a model of functional cure with persistent reservoirs of replication-competent virus Cristian Apetrei Center for Vaccine.
Future directions in HIV basic science research The hunt for a cure.
HIV-1 infection decreases CD127 and PD1 expression on duodenal CD8+T cells Liliana Belmonte, PhD Academia Nacional de Medicina Buenos Aires, Argentina.
CDER Meeting: Surrogate Markers of Immunity Presenter: Judith A. Britz, Ph.D. October 16, 2000.
IAS Members Meeting July 19th 2011 Achievements and learning over the past 30 years: what do we need next? Françoise BARRÉ-SINOUSSI Regulation of Retroviral.
HIV pathogenesis The course of HIV infection 1. Acute Phase 2. Intermediate (asymptomatic) phase -viral load stabilizes at a “set point”. 3. Late (symptomatic)
Immune reconstitution Anjie Zhen, PhD
The Negative Checkpoint Receptor TIGIT Marks Exhausted T cells During SIV Infection and Correlates with SIV Disease Progression Gabriela Webb Vaccine and.
HUMORAL IMMUNE RESPONSES HAVE LITTLE EFFECT ON CONTROLLING VIREMIA DURING SIVagm INFECTION OF AFRICAN GREEN MONKEYS Thaidra Gaufin Division of Microbiology.
IAS 2014, Melbourne Mechanisms of non-pathogenicity in HIV- Lessons from paediatric infection.
Background  HIV-1 infection persists in reservoirs and leads to progressive depletion of CD4+ T-cells even in subjects with slow disease progression 
Davey Smith, MD Professor of Medicine University of California San Diego La Jolla, California When Will It All Be Over? HIV Cure Efforts Los Angeles, California:
The AIDS resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus by Richard Dunham, Paola Pagliardini, Shari.
Dysbiotic bacteria drive suppressive neutrophil phenotypes and prolonged lifespan in mucosal tissues of HIV-infected individuals Nichole Klatt AIDS 2016,
The impact of treatment duration on defective and expanded identical HIV genomes in T cell subsets from peripheral blood and tissues Eunok Lee.
HIV-infected patients, and have proliferative defects
Rapporteur Report – Track A Basic and Translational Sciences
HIV Cure: Current Status and Future Perspectives
Center for Biomedical Research
HEATHER Feedback Meeting
Coinfection With HIV-1 and HCV—A One-Two Punch
by Jason M. Brenchley, Mirko Paiardini, Kenneth S. Knox, Ava I
Volume 45, Issue 3, Pages (September 2016)
Jason M. Brenchley, Guido Silvestri, Daniel C. Douek  Immunity 
HIV and Tfh Cells: Circulating New Ideas to Identify and Protect
Dwelling on T Cell Fate Decisions
Current model of CD8+ T-cell central and effector memory generation for mouse and human T cells. Current model of CD8+ T-cell central and effector memory.
Volume 47, Issue 4, Pages e5 (October 2017)
Volume 13, Issue 8, Pages (November 2015)
Coinfection With HIV-1 and HCV—A One-Two Punch
Theoretical Immunology: Aging
Volume 18, Issue 3, Pages (March 2003)
CD8+ T-cell subsets. CD8+ T-cell subsets. There are a number of different CD8+ T-cell subsets. Naïve, T stem cell (TSCM) and T central memory (TCM) cells.
Presentation transcript:

CD4+ memory stem cells (T SCM ) in pathogenic and non- pathogenic SIV infections Guido Silvestri, MD Yerkes National Primate Research Center Emory University School of Medicine Emory Center for AIDS Research (CFAR) Emory Vaccine Center

The pattern of Infected CD4+ T Cell is a key determinant of AIDS pathogenesis Damage to LN architecture & lymphoid niche Loss of CD4 T cell homeostasis/CD4 depletion Chronic immune activation Pattern of in vivo infected cells Features & efficacy of host immune responses Size and dynamics of the “latent” reservoir Picker. J Exp Med 2007; Letvin et al. Science 2007; Roederer et al. J Exp Med 2007; Brenchley et al. Immunity 2010; Chomont et al., Nat Med 2009; Paiardini et al. Nat Med 2011; Brenchley et al. Blood 2012; Autran et al., Clin Inf Dis 2012; Chahroudi et al., Science 2012; Saez-Cirion et al. PLoS Path 2013

Comparative AIDS Research AIDS NO YES YES Blood CD4 depletion Rare YES YES Viral Load HIGH HIGH HIGH SM RM HIV Preserved gut & LN integrity YES NO NO Microbial translocation NO YES YES Chronic immune activation NO YES YES

Restricted infection of CD4+ T CM cells in SIV-infected sooty mangabeys Level of infected cells in vivo Level of infected cells following in vitro infection Paiardini et al, Nat Med 2011

LN anatomic distribution of productively infected cells in RMs, humans, and SMs. (A) SIV/HIV vRNA + cells/mm 2 in LNs of chronically infected RMs, humans, and SMs. (B) SIV/HIV vRNA + in B-cell follicles (C) Percentage of LN area that consists of B-cell follicles. Brenchley et al, Blood 2012 Higher levels of Tfh infection in SIV-infected RMs and HIV-infected humans than SIV-infected SMs

Progressive Infection and AIDS Chronic, generalized Immune Activation How HIV and SIV infection cause AIDS: Lessons from natural SIV infections Virus replication in central memory CD4+ T cells

Naïve CellEffector (short-lived, activated) Memory cell pool Proliferation and clonal expansion in response to antigenic stimulation Contraction phase Effector Memory : Resident in periphery. Able to respond quickly to re-exposure. CD62L- CCR7- Central Memory : Resident in LNs, spleen. Able to self-renew and differentiate into Tem. CD62L+ CCR7+ Memory stem cell antigen Complexity of the memory CD4+ T cell pool

What is a T memory stem cell (Tscm)? 1-3% of circulating and LN-based CD4+ and CD8+ T cells. Identified by classical naïve T cell markers (CD45R+CD45RO- CD62L+CCR7+CD127+CD27+CD28+), but also CD95 & CD122. Express more LFA-1 and CXCR3 than naïve cells, but less than T CM (and less Bcl-2 than naïve cells but more than T CM ). Least differentiated memory subset, with high proliferative potential, and capable of self-renewal. Multipotent: able to generate both T CM and T EM Gattinoni et al., Nat Med 2009; Turtle et al., Immunity 2009; Muranski et al., Immunity 2011; Gattinoni et al., Nat Med 2011; Luckey CJ, Weaver CT. Cell Stem Cell, 2012; Roederer et al., J Clin Invest, 2012

A.A. T SCM CD8 FSC-H CD95 SSC-A CCR7 Dead/14/16/20 CD27 CD45RACD28CD4 CD122 FSC-ACD3FSC-A Identification of CD4+T SCM in healthy rhesus macaques and sooty mangabeys. E.E. C. B.B. D.

A.A. E.E. C. B.B. D. F. Identification of CD4+T SCM in healthy rhesus macaques and sooty mangabeys.

B. C. CD4+ T SCM express levels of CXCR3 and CD11a similar to other memory CD4+ T cells subsets, and levels of Bcl-2 that are intermediate between naïve and T CM.

A.A. Higher levels of CCR5 expression on CD4+T SCM of healthy RMs as compared to SMs. C. B.B. D. E.E. F.F. CD4 SM RM CCR5

Selective preservation of CD4+T SCM cells during pathogenic SIV infection of RMs B.D. A. p= n.s.

SIV infection of RMs is associated with a significant depletion of CCR5+CD4+T SCM. A. B.B. C.

SIV infection of RMs is associated with increased proliferation of CD4+T SCM that significantly inversely correlates with the levels of CD4+T CM A. B. C. D.

A. B. C. Dynamics of CD4+T SCM during non-pathogenic infection of SM D.

Robust levels of CD4+T SCM infection in vivo are observed in SIV-infected RMs but not in SIV-infected SMs

CD4+ T memory stem cells in pathogenic and non-pathogenic SIV infections CD4+ T SCM are numerically preserved during BOTH pathogenic and nonpathogenic SIV infections. However, SIV-infected RM show (i) a selective depletion of CD4+CCR5+ T SCM ; and (ii) higher levels of CD4+ T SCM proliferation that correlate significantly with the level of CD4+ T CM depletion. Robust levels of direct virus infection of CD4+ T SCM are found only in SIV-infected RM, with 6 out of 7 SIV-infected SM showing no evidence of CD4+ T SCM infection.

CD4+ T memory stem cells in pathogenic and non-pathogenic SIV infections RM SM T SCM T CM CCR5+Ki67+ T SCM T CM SIV AIDS T SCM T CM

Increasing contribution of Tscm to HIV reservoir over time (M. Lichterfeld) Lichterfeld, unpublished

Hypothesis: can reservoirs be eliminated when there is no virus in T SCM cells? T SCM T CM T EM ART T SCM T CM T EM Persistent T SCM (and T CM ) reservoirs Absence of T SCM (and T CM ) reservoirs

Acknowledgments Silvestri Lab Emily Cartwright Vandy Vanderford Steven Bosinger Ann Chahroudi Ankita Chowdhury Maud Mavigner Kiran Mir Tim Hayes Luca Micci Tayebeh Hashempour Charlene Wang Alex Ortiz (NIH) Nichole Klatt (UW) Diane Carnathan Paul Carnathan SBRI -- Seattle Donald Sodora Emory University/Yerkes Mirko Paiardini Colleen McGary Cynthia Derdeyn James Else Eric Hunter Vincent Marconi Ray Schinazi NIH/NIAID/NCI Jake Estes Jason Brenchley Daniel Douek Univ. of Pennsylvania Ron Collman Mike Betts Beatrice Hahn Univ. of Ulm Frank Kirchhoff Ragon Institute/HMS Mathias Lichterfeld Case Western Michael Lederman Institut Pasteur Michaela Muller-Trutwin University of Pittsburgh Ivona Pandrea Cristian Apetrei Los Alamos National Labs Alan Perelson Supported by NIH/NIAID, Emory CFAR, Georgia Research Alliance